Mitochondrial division inhibitor (Mdivi-1), a putative inhibitor of Drp1, prevents mitochondrial fission and thereby restricts cell proliferation across several types of oral squamous cell carcinoma, thyroid cancer, breast cancer and so on [47–49]. Here, DNM1L is linked to breast carcinoma.